Search PubMed⌕ Search

Biomedical subjects

X Gao

Publications and source records attributed to X Gao.

At least 307 records · Page 17Linked to original sources

Effects of previous use of oral contraceptives on early follicular phase follicle-stimulating hormone.

OBJECTIVE: To determine if previous oral contraceptive (OC) use is associated with changes in early follicular phase FSH, LH or E2. DESIGN: A cross-sectional study examining determinants of early follicular phase hormone levels. SUBJECTS: Subjects included 106 premenopausal women with a family history of ovarian cancer and 116 premenopausal women without this history who were not taking OCs currently. All subjects completed a structured interview and gave an early follicular phase blood sample. SETTING: Gynecologic Epidemiology Center and Familial Ovarian Cancer Research Center. MAIN OUTCOME MEASURES: Follicle-stimulating hormone, LH, and E2 were measured in early follicular phase plasma samples. RESULTS: Recency or length of prior OC use did not affect early follicular phase LH or E2 levels. Length of OC use did not affect FSH levels in all subjects; but lower levels of FSH were observed in women over age 45 who had used OCs for > 5 years. Early follicular phase FSH is lower in women with OC use within the past 5 years compared with women with more remote use or who never used OCs, after adjustment for age, smoking, and family history status. CONCLUSIONS: Past use of OCs may have a residual effect on basal FSH levels in women not using them currently that depends on recency of use and to a lesser extent duration of prior use.

Adult↗

Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.

OBJECTIVES: Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in males in the United States. The mortality is due mainly to distant metastasis. Therefore, predicting the prognosis of prostate cancer patients is an important clinical problem. Previously, we demonstrated that a 12-lipoxygenase (12-LOX) metabolite of arachidonic acid, 12(S)-hydroxyeicosatetraenoic acid, enhances the invasiveness of prostate cancer cells and that a 12-LOX-selective inhibitor [N-benzyl-N-hydroxy-5-phenylpentanamide] reduces experimental metastasis in animal model systems. In this study, we investigated the potential of 12-LOX as a predictor for the aggressiveness of prostate cancer. METHODS: The mRNA expression level of 12-LOX in 122 matching prostate normal and cancerous tissues were measured by quantitative reverse transcription- polymerase chain reaction. Possible association between 12-LOX expression and histologic grade, pathologic and clinical stage, margin positivity, age, and race was analyzed. RESULTS: 12-LOX mRNA levels were elevated in cancer cells and the expression associated with poor differentiation and invasiveness of prostate cancer. Overall, 46 (38%) of 122 evaluable patients showed elevated levels of 12-LOX mRNA in prostate cancer tissues compared with the matching normal tissues. A statistically significantly greater number of cases were found to have an elevated level of 12-LOX among T3, high grade, and surgical margin-positive than T2, intermediate, and low grade, and surgical margin-negative prostatic adenocarcinomas. CONCLUSIONS: Our data suggest that elevation of 12-LOX mRNA expression occurs more frequently in advanced stage, high-grade prostate cancer and that 12-LOX may serve as an indicator for progression and prognosis of prostate cancer. This enzyme also may be a novel target for the development of anti-invasive and antimetastatic agents.

Adenocarcinoma↗

Use of drug kinetics in dermis to predict in vivo blood concentration after topical application.

PURPOSE: To use the drug kinetics in dermis to predict the in vivo blood concentration after topical administration. METHODS: A two-step pharmacokinetic model was established. The first step was to calculate the drug input rate or flux from the skin to the systemic circulation using the drug kinetic parameters in dermis. These parameters include (a) distance over which the drug concentration declines by 50%, (b) drug concentration at the epidermal-dermal junction, and (c) minimal plateauing drug concentration in the muscle layer. These parameters were experimentally determined from the drug concentration-tissue depth profiles in the dermis, after the application of a topical dose of ddI (200 mg/kg) to rats. The second step was to use the drug input rate together with the systemic disposition pharmacokinetics of ddI in rats to predict the plasma concentration-time profiles. The model-predicted plasma concentration-time profiles were compared with the observed profiles, to determine the validity of the proposed pharmacokinetic model. RESULTS: The observed steady state concentration (CSS) in individual animals (n = 6) deviated from the predicted values by 3 to 55% with 3 of 6 rats showing a < 15% deviation. The mean observed CSS of all animals deviated from the mean predicted values by less than 15%. CONCLUSIONS: The close agreement between the observed and the model-predicted drug concentrations indicates that the systemic drug input can be calculated from the drug kinetics in the dermis.

Administration, Topical↗

Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.

PURPOSE: To evaluate the intratracheal route of administration as an alternative to oral administration for 2',3'-dideoxyinosine (ddI). METHODS: A ddI dose (40 mg/kg/300 microliters or 6.5 mg/kg/50 microliters) was instilled into the trachea in female Fisher rats and an intravenous tracer dose (9 micrograms/kg) of 3H-ddI was administered concomitantly to determine the drug clearance. Plasma concentrations were analyzed for the rate and extent of absorption. RESULTS: ddI was rapidly absorbed from the lungs, with a bioavailability of 63% at 40 mg/kg and 101% at 6.5 mg/kg. By comparison, our previous data showed an oral bioavailability of about 15% (Pharm Res., 9:822, 1992). The distribution of a dye solution instilled intratracheally showed that a fraction of the 300 microliters dose spilled over to the gastrointestinal tract, where the entire 50 microliters dose was retained in the lungs. The different distribution of the two doses volumes likely contributed to the different bioavailability, with a fraction of the higher dose/volume degraded in the gastrointestinal tract after the spillover. Absorption of ddI from the airspace of the lung was biexponential, suggesting two absorption processes. CONCLUSIONS: These data indicate significantly higher and less variable bioavailability of ddI by the intratracheal route of delivery compared to the oral route. Furthermore, the complete bioavailability at the lower dose/volume indicates no significant pulmonary first pass elimination for ddI.

Absorption↗

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

We report the results of a double-blind, placebo-controlled trial in nine cystic fibrosis (CF) subjects receiving cationic liposome complexed with a complementary DNA encoding the CF transmembrane conductance regulator (CFTR), and six CF subjects receiving only liposome to the nasal epithelium. No adverse clinical effects were seen and nasal biopsies showed no histological or immuno-histological changes. A partial restoration of the deficit between CF and non-CF subjects of 20% was seen for the response to low Cl- perfusion following CFTR cDNA administration. This was maximal around day three and had reverted to pretreatment values by day seven. In some cases the response to low Cl- was within the range for non-CF subjects. Plasmid DNA and transgene-derived RNA were detected in the majority of treated subjects. Although these data are encouraging, it is likely that transfection efficiency and the duration of expression will need to be increased for therapeutic benefit.

Base Sequence↗

Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement.

Epidemiologic studies suggest that women who consume ethanol are at an increased risk for developing breast cancer. Two randomized, crossover studies were performed to examine the effects of ethanol on prolactin in menopausal women using transdermal estradiol. In study 1, transdermal estradiol patches (0.15 mg) were administered to menopausal women (n = 7) the day before ethanol administration. At 8.00 h, the women ingested ethanol (1 ml/kg, 95% ethanol) or an isocaloric carbohydrate drink. Prolactin levels were measured frequently for 6.3 h. Serum ethanol levels reached a broad peak from 40 to 100 min after initiation of ethanol ingestion. Serum prolactin levels were significantly higher after ethanol ingestion than after the isocaloric carbohydrate drink ingestion (p < 0.03). Study 2 was identical to study 1 except that the transdermal estradiol patches were removed after completion of ethanol or carbohydrate ingestion. In study 2, serum prolactin was greater after ethanol ingestion than after carbohydrate ingestion (p < 0.001). In menopausal women using transdermal estradiol, acute ethanol ingestion is associated with an increase in serum prolactin.

Administration, Cutaneous↗

Changes in kininogens and kallikrein in the plasma, brain, and uterus during pregnancy in the rat.

Bradykinin is a potent inducer of uterine smooth muscle contractions in rodents and primates. Hence, the purpose of the present study was to characterize the various components of the kinin system in the plasma, uterus, hypothalamus, and anterior pituitary of the rat during pregnancy to determine whether the kinin system is involved in the regulation of uterine contractility during pregnancy. To achieve this aim, timed pregnant rats were used, groups of animals (n = 6 per group) were killed on days 5, 15, 20, 21, and 22, and measurements of kininogen and kallikrein activity were performed on plasma and selected tissues. A nonpregnant control group was also used, consisting of a group of 10 randomly cycling rats. The results of the study revealed that total kininogen levels in the plasma rose during pregnancy (days 15-22) to peak on day 22, the day of parturition. This rise was due to increases primarily in T-kininogen compared to low mol wt (LMW) kininogen. Total kininogen levels in the hypothalamus were undetectable during pregnancy; however, anterior pituitary kininogen levels increased markedly from days 15-22. Hypothalamic kallikrein activity was very markedly increased from days 5-20 only to drop on days 21 and 22 of pregnancy. Uterine total kininogen levels were low from days 5-20 of pregnancy, only to undergo a marked elevation on days 21 and 22 (the day of parturition). This elevation on day 21 was due to increased T- and LMW kininogen levels. Uterine LMW kininogen levels were elevated on day 21, followed by a marked fall on day 22. This fall was most likely due to increased bradykinin production from LMW kininogen, because uterine kallikrein activity was significantly elevated on days 21 and 22. The increased production of bradykinin in the uterus on the day of parturition could play a significant role in the mechanism responsible for activation of uterine contractions during this event.

Animals↗

[Western medical books translated by J. Dudgeon].

John Dudgeon (1837-1901) was a famous medical missionary in Modern China. He not only translated traditional Chinese medicine, arts of Chinese healing and Chinese culture and introduced them to European, but also translated Western medicine, science and technique and introduced them to Chinese. Dudgeon had introduced Western anatomy, physiology and clinical experience. This author claimed that Dudgeon transfered a new kind of mankind concept and methodology during his translative career, and the later was even more important for Chinese scholars and Chinese academic circles.

China↗

Bcl-2 relieves deoxyadenylate stress and suppresses apoptosis in pre-B leukemia cells.

The influence of bcl-2 activity on 2'-deoxyadenosine-induced apoptosis was investigated in 697 human pre-B leukemia cells stably transfected with expression plasmid pHeBo-BCL-2alpha (697/BCL2 cells). Apoptosis was induced by the 2'-deoxyadenosine analogue, 2-chloro-2'-deoxyadenosine (Cl-dA), with the concentration for apoptosis in one-half of the cells at 24 hours (LD(50)) being 10 microM for 697 cells and 120 microM for 697/Bcl 2 cells. There was a strong positive correlation between Cl-dATP levels and apoptotic index (coefficient of determination, r(2)=0.95; P=0.027). When 697 cell and 697/Bcl 2 cell lines were treated with 5 microM Cl-dA, Cl-dATP did not significantly accumulate in the latter. The Cl-dATP/dATP ratio was 0.03 in Cl-dA treated 697/Bcl 2 cells but nearly 6 in treated 697 cells. Bcl 2 overproduction also suppressed the accumulation of dAMP, dADP and dATP in cells exposed to 2'-deoxyadenosine in the presence of pentostatin to abrogate the pronounced inversion of ATP/dATP pools associated with 2'-deoxyadenosine exposure. These results suggest that one consequence of bcl-2 activity is suppression of 2'-deoxyadenosine phosphorylation and elevation in the apoptotic target cells. Relief from deoxyadenylate stress imbalances implies a novel upstream site of bcl-2 activity.

Journal Article↗

[Exploration on experimental conditions of dot-ELISA for Trichomonas vaginalis using intact parasite antigen-monoclonal antibody detecting system].

This paper deals with the effect of different experimental conditions including the number of parasite, blocking fluid, incubation time and different types of antigens on dot-ELISA for Trichomonas vaginalis. Five microlitres of freshly washed intact worms at a concentration of 7.7 x 10(5)-3 x 10(8) cells/ml were added onto nitrocellulose membrane blocked with 1% BSA, 10% bovine serum or milk power (0.1%, 0.25%, 0.5%, 5%). Dot-ELISA using nitrocellulose membrane containing whole cell antigen 2.5 x 10(7) cells/ml, blocked by 0.5% defatted milk power at 37 degrees C for one hour before the incubation in McAb, incubated at 37 degrees C for one hour in McAb and SPA respectively was found to give more promising results. The whole cell antigen could be preserved for four months at 4 degrees C and -20 degrees C.

Animals↗

[Study on the optimums for Pseudomonas maltophilia HCG receptor expression].

According to the design of orthogonal experiment, the optimums for expression of Pseudomonas maltophilia with HCG receptor were studied by radioassay. The results showed that the optimums influencing the specific binding percentage of Pseudomonas maltophilia were the cultures of No. 3 solid medium added with 0.5% galactose and incubated at a temperature of 37 C for 72 hours. Under these conditions, the binding percentage of Pseudomonas maltophilia to HCG was higher than those under other conditions.

Pseudomonas↗

The effects of ethanol on the clearance of estradiol in postmenopausal women.

OBJECTIVE: To determine whether acute alcohol ingestion affects the pattern of decline of circulating E2 levels after removal of transdermal E2 patches. DESIGN: A randomized, placebo-controlled, crossover study. SETTING: The study was performed in the Clinical Research Center of the Brigham and Women's Hospital. PARTICIPANTS: Twelve healthy postmenopausal women were enrolled. INTERVENTIONS: Transdermal E2 patches, 0.15 mg, were applied 13 hours before subjects ingested alcohol (1 mL/kg 95% ethanol) or carbohydrate placebo punch. The patches were removed immediately after drink ingestion. MAIN OUTCOME MEASURES: Estradiol, estrone (E1), and ethanol levels were measured. RESULTS: Serum samples were obtained for 40 minutes before drink ingestion and 5 hours after drink ingestion and E2 patch removal. At the time of patch removal, E2 levels rose acutely over 10 minutes and then decreased rapidly, suggesting a bolus effect that was more marked after ethanol ingestion. After ethanol ingestion and patch removal the half-life of E2 was calculated to be 378 minutes, and after carbohydrate punch and patch removal 245 minutes. There were no significant changes in E1 concentrations over the time course of the study between groups. CONCLUSIONS: Ethanol ingestion may decrease E2 clearance after removal of transdermal E2 patches.

Administration, Cutaneous↗

[Effects of different fixatives for Trichomonas vaginalis in indirect fluorescent antibody test].

This paper dealt with the effects of different fixatives for Trichomonas vaginalis in indirect fluorescent antibody test. T. vaginalis fixed by formalin, methanol or alcohol displayed clear flagella. The parasites fixed by methanol and alcohol showed specific ring-like fluorescence with 1-2 bright dots. Antigen slides prepared from different Trichomonas strains, different number of parasites and anti-Trichomonas vaginalis McAb strains in IFA presented different results. Antigen slides showed the best results when using parasites at concentrations of 1.2 x 10(6) cells/ml or 2.4 x 10(5) cells/ml. Antigen preparations stored at 4 degrees C or -20 degrees C remained reactive throughout the experimental period of three months.

Animals↗

In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE.

Clinical trials using cationic liposome-mediated DNA transfer have now been initiated for several disorders including cystic fibrosis. Previous studies have shown that the level of gene expression achieved may be dependent on the formulation of the DNA-liposome complex and the cell type transfected. We have investigated, in vitro, the effect of parameters such as DNA:liposome ratio, dose and concentration on the level of transgene expression in epithelial cell lines using the cationic liposome DC-Chol/1,2-dioleoyl phosphatidylethanolamine (DOPE). A narrow range of conditions was found to produce maximal level of transgene expression within a particular cell line, as detected using the reporter molecule beta-galactosidase (beta-gal). beta-Gal expression was significantly enhanced by formulation of the DNA-DC-Chol/DOPE complexes in physiological solution at pH 9.0. Under standard in vitro transfection conditions, increased incubation time of the DNA-liposome complexes with cells resulted in increased transgene expression. In contrast, at relatively high DNA and liposome dose and concentrations, beta-gal activity was maximal after only 1 h of incubation, with a subsequent decrease in expression with time. The maximum level of expression that could be produced using fully optimised transfection conditions, however, was still highly dependent on each cell type analysed. Correlation of these findings with similar studies in vivo are now critical to determine the optimal formulation of DNA-liposome complexes for clinical application.

Animals↗